NCT04740398View on ClinicalTrials.gov

A Study of CBP-1008 in Patients With Advanced Solid Tumor

PHASE1RecruitingINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Advanced Solid Tumor
Interventions
DRUG

CBP-1008

CBP-1008 for injection; IV infusion; Infusion for 90 minutes

Trial Locations (3)

100000

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

200000

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Coherent Biopharma (Suzhou) Co., Ltd.

INDUSTRY

NCT04740398 - A Study of CBP-1008 in Patients With Advanced Solid Tumor | Biotech Hunter | Biotech Hunter